Cargando…
An Integrated Genomic Strategy to Identify CHRNB4 as a Diagnostic/Prognostic Biomarker for Targeted Therapy in Head and Neck Cancer
Although many studies have shown the association between smoking and the increased incidence and adverse prognosis of head and neck squamous cell carcinoma (HNSCC), the mechanisms and pharmaceutical targets involved remain unclear. Here, we integrated gene expression signatures, genetic alterations,...
Autores principales: | Chuang, Yi-Hsuan, Lee, Chia-Hwa, Lin, Chun-Yu, Liu, Chia-Lin, Huang, Sing-Han, Lee, Jung-Yu, Chiu, Yi-Yuan, Lee, Jih-Chin, Yang, Jinn-Moon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281299/ https://www.ncbi.nlm.nih.gov/pubmed/32455963 http://dx.doi.org/10.3390/cancers12051324 |
Ejemplares similares
-
Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer
por: Chuang, Yi-Hsuan, et al.
Publicado: (2023) -
Identification of CHRNB4 as a Diagnostic/Prognostic Indicator and Therapeutic Target in Human Esophageal Squamous Cell Carcinoma
por: Li, Nan, et al.
Publicado: (2020) -
Membrane protein-regulated networks across human cancers
por: Lin, Chun-Yu, et al.
Publicado: (2019) -
Reply to Zhu et al.: Implications of CHRNB1 and ERBB2 in the pathobiology of myasthenia gravis
por: Chia, Ruth, et al.
Publicado: (2022) -
Convolutional neural network for human cancer types prediction by integrating protein interaction networks and omics data
por: Chuang, Yi-Hsuan, et al.
Publicado: (2021)